Abstract
Artesunate, a semi-synthetic derivative of artemisinin, is used primarily as a treatment for malaria. Its effects on the central nervous system, general behavior, and cardiovascular, respiratory, and other organ systems were studied using mice, rats, guinea pigs, and dogs. Artesunate was administered orally to mice at doses of 125, 250, and 500 mg/kg and to rats and guinea pigs at 100, 200, and 400 mg/kg. In dogs, test drugs were administered orally in gelatin capsules at doses of 50, 100, and 150 mg/kg. Artesunate induced insignificant changes in general pharmacological studies, including general behavior, motor coordination, body temperature, analgesia, convulsion modulation, blood pressure, heart rate (HR), and electrocardiogram (ECG) in dogs in vivo; respiration in guinea pigs; and gut motility or direct effects on isolated guinea pig ileum, contractile responses, and renal function. On the other hand, artesunate decreased the HR and coronary flow rate (CFR) in the rat in vitro; however, the extent of the changes was small and they were not confirmed in in vivo studies in the dog. Artesunate increased hexobarbital-induced sleeping time in a dose-related manner. Artesunate induced dose-related decreases in the volume of gastric secretions and the total acidity of gastric contents, and induced increases in pH at a dose of 400 mg/kg. However, all of these changes were observed at doses much greater than clinical therapeutic doses (2.4 mg/kg in humans, when used as an anti-malarial). Thus, it can be concluded that artesunate is safe at clinical therapeutic doses.
Article PDF
Similar content being viewed by others
References
Arnold, K., Hien, T.T., Chinh, N.T., Phu, N.H. and Mai, P.P. (1990). A randomised comparative study of artemisinin (qing-haosu) suppositories and oral quinine in acute falciparum malaria. Trans. Roy. Soc. Trop. Med. Hyg., 84, 499–502.
Bolli, R. (1991). Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs. Ther., 5, 249–268.
Brewer, T.G., Grate, S.J., Peggins, J.O., Weina, P.J., Petras, J.M., Levine, B.S., Heiffer, M.H. and Schuster, B.G. (1994a). Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg., 51, 251–259.
Brewer, T.G., Peggins, J.O., Grate, S.J., Petras, J.M., Levine, B.S., Weina, P.J., Swearengen, J., Heiffer, M.H. and Schuster, B.G. (1994b). Neurotoxicity in animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg., 88, S33–S36.
Brewer, T.G., Genovese, R.F., Newman, D.B. and Li, Q. (1998). Factors relating to neurotoxicity of artemisinin antimalarial drugs “listening to arteether”. Med. Trop. (Mars.), 58, 22–27.
Cao, X.T., Bethell, D.B., Pham, T.P., Ta, T.T., Tran, T.N., Nguyen, T.T., Pham, T.T., Nguyen, T.T., Day, N.P. and White, N.J. (1997). Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Trans. Roy. Soc. Trop. Med. Hyg., 91, 335–342.
Carlini, E.A. (1973). Farmacologia Pratica sem Aparelhagem, Sarvier, Editorade Livros Medicos Ltd., Sao Paulo, 145–197 as cited by Hellion-lbarrola et al., 1999. Journal of Ethnopharma-cology 66, 271–276.
Chen, H.H., Zhou, H.J. and Fang, X. (2003). Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol. Res., 48, 231–236.
Classen, W., Altmann, B., Gretener, P., Souppart, C., Skelton-Stroud, P. and Krinke, G. (1999). Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs. Exp. Toxicol. Pathol., 51, 507–516.
Dell’Eva, R., Pfeffer, U., Vené, R., Anfosso, L., Forlani, A., Albini, A. and Efferth, T. (2004). Inhibition of angiogenesis in vivo and growth of Kaposi’s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmacol., 68, 2359–2366.
Dunham, W.W and Miya, TS. (1957). A note on a simple apparatus of detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc, 10, 208–209.
Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H. and Chitambar, C.R. (2001). The anti-malarial artesunate is also active against cancer. Int. J. Oncol., 18, 767–773.
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H.O., Hengstler, J.G., Halatsch, M.E., Volm, M., Tew, K.D., Ross, D.D. and Funk, J.O. (2003). Molecular modes of action of artesunate in tumor cell lines. Mol. Pharmacol., 64, 382–394.
Ha, V., Nguyen, N.H., Tran, T.B., Bui, M.C., Nguyen, H.P., Tran, T.H., Phan, T.Q., Arnold, K. and Tran, T.H. (1997). Severe and complicated malaria treated with arteminisin, artesunate or artemether in Viet Nam. Trans. Roy. Soc. Trop. Med. Hyg., 91, 465–467.
Irwin, S. (1968). Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia (Berl.), 13, 222–257.
Koster, R., Anderson, M. and De Beer, E.J. (1959). Acetic acid for analgestic screening. Fed. Proc, 18, 412–418.
Maude, R.J., Plewes, K., Faiz, M.A., Hanson, J., Charunwatthana, P., Lee, S.J., Taming, J., Yunus, E.B., Hoque, M.G., Hasan, M.U., Hossain, A., Lindegardh, N., Day, N.P., White, N.J. and Dondorp, A.M. (2009). Dose artesunate prolong the electrocardiograph QT interval in patients with severe malaria?. Am. J. Trop. Med. Hyg., 80, 126–132.
Michaelis, M., Kleinschmidt, M.C., Barth, S., Rothweiler, F., Geiler, J., Breitling, R., Mayer, B., Deubzer, H., Witt, O., Kreuter, J., Doerr, H.W., Cinatl, J. and Cinatl, J. Jr. (2010). Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem. Pharmacol., 79, 130–136.
Park, B.K., O’Neill, P.M., Maggs, J.L. and Pirmohamed, M. (1998). Safety assessment of peroxide antimalarials: clinical and chemical perspectives. Br. J. Clin. Pharmacol., 46, 521–529.
Price, R.N. (2000). Artemisinin drugs: novel antimalarial agents. Expert. Opin. Investig. Drugs., 9, 1815–1827.
Ribeiro, LR. and Olliaro, P. (1998). Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med. Trop. (Mars.), 58, 50–53.
Shay, H., Komarov, S.A., Fels, S.S., Meranze, D., Gruenstein, M., and Siplet, H. (1945). A simple method for the uniform production of gastric ulceration in rats. Gastroenterology, 5, 43–61.
Singh, N.P. and Lai, H. (2001). Selective toxicity of dihydroarte-misinin and holotransferrin toward human breast cancer cells. Life. Sei., 70, 49–56.
Svensson, T.H. and Thieme, G. (1969). An investigation of a new instrument to measure motor activity of small animals. Psy-chopharmacologia (Berl), 14, 157–163.
Swinyard, E.A., Brow, W.C. and Goodman, L.S. (1952). Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther., 106, 319–330.
Truett, A.A. and West, D.B. (1995). Validation of a radiotelemetry system for continuous blood pressure and heart rate monitoring in dogs. Lab. Anim. Sci., 45, 299–302.
Watts, J. and Maiorano, L. (1987). Effects of diltiazem upon globally ischemic rat hearts. Eur. J. Pharmacol., 138, 335–342.
White, N.J. (2007). Cardiotoxicity of antimalarial drugs. Lancet., 7, 549–558.
Woodbury, L.A. and Davenport, V.D. (1952). Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Arch. Int. Pharmacodyn., 92, 97–107.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lee, HA., Kim, KS. & Kim, EJ. General Pharmacology of Artesunate, a Commonly used Antimalarial Drug: Effects on Central Nervous, Cardiovascular, and Respiratory System. Toxicol Res. 26, 223–232 (2010). https://doi.org/10.5487/TR.2010.26.3.223
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2010.26.3.223